The current study aims to investigate the effect of anti-osteoporotic agents of collared and non-collared femoral stem prostheses on periprosthetic bone mineral density (BMD) after total hip arthroplasty (THA). 80 patients who received THA due to femur neck subcapital fractures were involved. The treatment groups were given fosamax, caltrate D and Xianlinggubao for oral administration, whereas the control groups were only given caltrate D. BMD at the greater trochiter around the femoral stem prosthesis and at the femoral shaft 1.5-1.0 cm away from the distal femoral stem was tested using dual-energy X-ray absorptiometry (DEXA) scan. Meanwhile, BMD at the same sites on the uninjured side was also tested. The BMD at both sites in all groups decreased after implantation. In the collared groups, no significant difference was shown between the injured and uninjured sides at 12 days or 3 months (p > 0.001). At 6 months after implantation, significant differences were displayed at both sites between the treatment and control groups (p < 0.001). In the non-collared groups, significant differences were displayed at both sites between the treatment and control groups at 6-months postimplantation (p < 0.001). No significant difference showed between the collared and non-collared groups show any at either site on either side (p > 0.05). DEXA scan can quantitatively determine bone loss around the prosthesis after THA. BMD around the prosthesis is correlated with administration of anti-osteoporotic agents. Fosamax + caltrate D + Xianlinggubao can prevent early bone loss around the prosthesis.
We present a case of pulmonary cryptococcosis presenting as wandering multiple bilateral shadows and hilar and mediastinal lymph node enlargement in which the fluconazole treatment suppressed the symptoms. This case illustrates the complex nature of immunological responses in the lungs and highlights the need to consider the existence of cryptococcal allergies.
[Purpose] To study preoperative and postoperative hip circumference data of various types
of congenital dysplasia of the hip treated with total hip replacement, including the
femoral offset, femoral neck length, height, and hip abductor arm parameters. [Subjects
and Methods] This study included seventy-eight cases of congenital dysplasia of the hip
(I–III type). Furthermore, four parameters were measured, including the preoperative and
postoperative femoral offset. Statistical data analysis was performed using the SPSS 13.0
software. [Results] The femoral offset was 33.3 ± 8.4 mm (preoperative) and 39.1 ± 7.1 mm
(postoperative). The femoral head height was 59.5 ± 8.7 mm (preoperative) and 68.8 ±
11.0 mm (postoperative). The femoral neck length was 50.8 ± 10.8 mm (preoperative) and
61.5 ± 10.4 mm (postoperative). The hip abductor arm was 54.3 ± 9.6 mm (preoperative) 64.7
± 10.1 mm (postoperative). The preoperative and postoperative parameters showed
statistical differences. Furthermore, no significant differences were evidenced when
comparing the postoperative hip parameters with the normal data parameters. [Conclusion]
Total hip replacement on congenital dysplasia of the hip could lead to the rebuilt of an
almost normal physiological anatomy for each hip case (type I–III).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.